Autoimmune antibodies to β2 glycoprotein I (β2GPI) have been proposed to be clinically relevant because of their strong association with thrombosis, miscarriage and thrombocytopenia. Using a homologous recombination approach, β2GPI-null mice were generated in order to begin to understand the physiologic and pathologic role of this prominent plasma protein in mammals. When β2GPI heterozygotes on a 129/Sv/C57BL/6 mixed genetic background were intercrossed, only 8.9% of the resulting 336 offspring
INTRODUCTION
β2 glycoprotein I (β2GPI) 1 also known as apolipoprotein H is a major protein constituent of plasma where its concentration approaches 0.2 mg/ml (1) . While the physiologic function of β2GPI has not been deduced, β2GPI interacts specifically with lipoprotein (a) (2) and the endothelial cell protein annexin II (3) . At least in vitro, β2GPI acts as an inhibitor of the intrinsic blood coagulation pathway (4), ADPmediated platelet aggregation, and the prothrombinase activity of activated platelets (5) . β2GPI binds to negatively charged cell surfaces such as those on activated platelets, probably by binding to negatively charged molecules such as heparan sulfate cell surface proteoglycans and antionic phospholipids. It is this latter property that has been proposed to be most clinically relevant. Interest in β2GPI increased dramatically shortly after it was discovered that this plasma protein is the most common antigen in patients with the "anti-phospholipid syndrome" (APS). (6) .
The term 'anti-phospholipid' is a misnomer because most of the antibodies generated in this human autoimmune disorder are not directed against phospholipids as first thought, but rather against the β2GPI component of the macromolecular complex.
The presence of anti-β2GPI antibodies in these patients correlates well with thrombosis, miscarriages, and thrombocytopenia (6) . Finally, β2GPI has been implicated in apoptosis (7) .
β2GPI is a single chain, 50-kDa protein consisting of 326 amino acids. It contains large numbers of Pro and Cys residues, and it is heavily glycosylated.
β2GPI is a member of the complement-control, short consensus-repeat superfamily The amino acid sequences of mouse and human β2GPI are 76% identical, and the β2GPI transcript in both species is ~1.2 kb in size. The nucleotide sequence of the entire mouse β2GPI gene has been deduced (8). It is ~18 kb in size and consists of eight exons.
Using a homologous recombination approach, we now describe the generation and initial characterization of transgenic mice unable to express β2GPI. NotI, electroporated into 2.5×10 7 embryonic stem (ES) cells (129/Sv). Clones were selected with G418 and gancyclovir according to the method described previously for other genes (10) . Single clones were selected after 10 days. Isolated DNA was digested with XbaI, separated by routine gel electrophoresis, and the resulting DNA blots were analyzed with a 32 P-labeled mouse β2GPI probe (0.4 kb), located within intron 4 just outside the targeting vector (named probe A).
An ES cell clone that had undergone homologous recombination was injected into C57BL/6 mouse blastocysts (10) and the resulting chimeric males were bred with C57BL/6 females. groups of 2-3 on the day at which a copulation plug was evident, nominated day 1 of pregnancy. Pregnant mice were sacrificed on day 18 of pregnancy for determination of numbers of implantation sites and platelet counts, or allowed to proceed to term for determination of litter size, individual pup weight and survival to weaning.
Coagulation Assays---All coagulation tests were performed on an Automated
Coagulation Machine (ACL-3000 Plus, Coagulation System Instrumentation Laboratory, Milano, Italy).
Mouse blood samples from 15 homozygous mutant mice and equal numbers of age and sex matched wild-type and heterozygous controls were collected in 0.11 M sodium citrate (9:1, v/v) via direct cardiac puncture as previously described.
Plasma was centrifuged at 3000 g for 20 min, collected, filtered through a 0.22 µm filter to remove platelet fragments and stored at -70°C until analysis.
The following coagulation tests was performed with each genotype plasma: 
Assay of Coagulation Factor Activities---The activity of the coagulation factors II, V,
VII, VIII, IX, X, XI and XII was determined as a clotting time after mixing the murine plasma with human plasma, deficient in the specific factor, and the addition of appropriate activator (13) . A standard curve was constructed by log-log plot of the clotting time (either aPTT or PT) of various dilutions of pooled β2GPI+/+ plasma (assumed to represent 100% activity). The specific factor activity of β2GPI+/-and β2GPI-/-plasma was derived as the mean activity of at least two dilutions extrapolated from the standard curve. All pro-coagulant activities were expressed as a percentage of the pro-coagulant activity in a pooled plasma of adult wild-type mice.
In Vitro Thrombin Generation Assay Using A Chromogenic Substrate---A chromogenic
assay was used to determine the rate of thrombin generation over time. The plasma used in this assay was defibrinated as follows: plasma was spun at 3000 x g for 20 min and filtered through 0.22 µm filter. Aliquots were collected in 1.5 ml eppendorf tubes and placed into a shaking water bath at 53°C for 20 min then centrifuged at 10000xg for 10 min. The supernatant was collected and stored at -70°C for use. All reagents in the thrombin generation assay were diluted in 0.9% NaCl. A mixture of 25 µl diluted (1:9) thromboplastin (Sigma), 25 µl 0.9% NaCl, and 50 µl 1:1 dilution of defibrinated plasma from the three groups of mice were added to wells of a microtiter plate and pre-warmed to 37°C for 10 min. Analysis of the β2GPI Mutation---Northern blot analysis was performed to confirm the loss of β2GPI gene expression in the surviving β2GPI -/-mice. As shown in Fig.2A , no transcript was observed in RNA samples isolated from liver tissue of β2GPI -/-mice when hybridized with a highly specific radiolabeled cDNA probe encoding exons 1-5 ( Fig. 2A) . In contrast, the expected 1.2 kb full-length transcript was present in the liver of β2GPI +/+ and +/-mice when analyzed in parallel. A β−actin probe was hybridized to the same blot after removal of the β2GPI probe to assess the amount of RNA loaded in each lane (lower panel in Fig.2A ) .
RESULTS

Generation of β2GPI-null mice---An
Based on the structure of the gene targeting construct, we expected that mice homozygous for the mutation would be unable to produce functional β2GPI protein.
Plasma from six-week-old mice was tested by Western blot using a rabbit polyclonal anti-β2GPI antibody. The antibody reacted with the expected 50 kDa protein band present in wild-type and β2GPI +/-mice (Fig. 2B) . However, no such immunoreactive band was detected in the plasma from β2GPI -/-mice.
Furthermore, analysis of serial dilutions of plasma from +/+ and +/-mice (Fig. 2C) revealed that the heterozygotes contained approximately half the concentration of The mean + SD litter size was 9.2 + 2.2 pups (total of 39 litters), of which 97%
(347/357) were viable at 24 h of age. Genotypes of the progeny were determined at 3 wk of age. Of the 336 successfully genotyped offspring , 121 were wild-type, 185
were heterozygous, while only 30 were homozygous for the disrupted allele, which
Is a statistically significant (p<0.005) deviation from the expected 1:2:1 ratio.
Macroscopic an histological examination of heart, lung, thymus, spleen, lymph nodes, liver, gall bladder, kidneys, urinary bladder, reproductive tract, stomach, small intestine, caecum, colon, pancreas, brain, eyes and skeletal muscle did not reveal any gross pathological changes associated with the homozygous mutation.
The effect of homozygous mutation on reproductive performance was investigated in further experiments. Initially, β2GPI -/-and β2GPI +/+ male mice were mated with C57BL/6 female mice. Each of six males from each genotype mated successfully with females and sired pregnancies. Female β2GPI -/-and β2GPI +/+ mice were then mated naturally with adult stud males of the same genotype and pregnancies were allowed to proceed to term. Neither the interval between placing with males and discovery of a vaginal plug, nor the proportion of plugged females delivering live pups, was affected by the β2GPI genotype. The by guest on April 8, 2017
http://www.jbc.org/ duration of pregnancy, the number of pups born, and their viability and weight at 24 h and at weaning were comparable in β2GPI -/-and β2GPI +/+ pregnancies (Table   I) , indicating a normal reproductive potential for β2GPI -/-mice.
To determine the effect of β2GPI deficiency on platelet counts in pregnancy, blood was recovered by cardiac puncture from adult virgin β2GPI -/-and β2GPI +/+ mice on day 18 of pregnancy and from β2GPI -/-and β2GPI +/+ female mice mated naturally with adult stud males of the same β2GPI status. While pregnancy was associated with an increase in mean blood platelet count of 35%, there was no significant effect of β2GPI deficiency in either the virgin or pregnant state (Table II) .
Furthermore, there was no effect of β2GPI deficiency on the number of implantation sites at day 18 (mean + SD = 9.3 + 2.9 in β2GPI +/+ mice and 8.2 + 2.8 in β2GPI -/-mice, n=6 per group) or on the proportion of resorption sites (5/56 in β2GPI +/+ mice and 1/49 in β2GPI -/-mice, n = 6 per group).
Characterization of the Coagulation Profiles of β2GPI+/+, β2GPI+/-and β2GPI-/-Mice---
The role of β2GPI in coagulation profiles was examined using a number of haematological parameters. Analysis of pooled plasma from β2GPI+/+, β2GPI+/-and β2GPI-/-mice (5 mice in each group, the experiment has been repeated on three occasions) revealed no significant differences in dKCT, dRVVT, aPTT nor protein C pathways among the three groups of animals (Table III) .
The activity of coagulation factors II, V, VII, VIII, IX, X, XI and XII were assessed in the three mouse genotypes. Specific factor assays in normal and defibrinated plasma revealed similar levels for the factors assayed in all three genotypes (data not shown). 
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In the in vitro chromogenic assay of thrombin generation the pooled plasma samples (Fig. 3A) or the individual plasma samples (Fig. 3B ) from β2GPI-/-mice had significantly less thrombin generation compared to that obtained from β2GPI+/+ or β2GPI+/-mice. Figure 3A demonstrates that the average time point required to reach half maximum optical density (OD405nm=0.55) was 1050 s for β2GPI+/+ mice, and 2100 s for the β2GPI+/-mice. In contrast, plasma from β2GPI-/-mice did not reach the half maximum optical density even after 3000 s. Similar results were obtained when plasma from two further groups of 15 mice were analysed in the thrombin generation assay. Mixing equal parts of β2GPI+/+ and β2GPI-/-mouse plasma produced a thrombin generation curve similar to that of the heterozygote plasma (data not shown).
The mean value (OD 405nm) of thrombin generation of 10 individual plasma samples from each population of animals ( Fig. 3B ) was measured at 1000 s. The mean value for β2GPI-/-was 0.175, which represents 69% less than the result for β2GPI+/+ mice and 40% less than that for β2GPI+/-mice. The difference in thrombin generation between β2GPI+/+, and β2GPI-/-mice was highly significant by one way Anova (p=0.0051). Together, these data show that β2GPI is not essential for normal reproductive function. However, the data from heterozygote pregnancies indicate that β2GPI deficiency might pose a selective disadvantage to survival of a conceptus gestating in a β2GPI replete maternal environment. Since litter sizes were comparable in heterozygote and wild-type pregnancies, any loss of β2GPI -/-embryos might occur early in pregnancy at, or prior to, the time of implantation. However because gancyclovir can induce non-specific point mutations in genes, we cannot rule out the One of the most striking observations of the β2GPI -/-mice is that they have a significantly diminished rate of thrombin generation compared to β2GPI +/+ and β2GPI +/-mice. However, no significant differences in clotting time were observed in plasma from these three genotypes when measured by dRVVT, dKCT, aPTT and protein C pathway assays. Our data demonstrates that the reduction or absence of β2GPI diminishes thrombin generation in a dose-dependent manner. A similar prolongation of thrombin generation was observed following the addition of anti-β2GPI antibodies to normal human plasma, regardless of whether the antibody was of mouse monoclonal or APS patient origin (14) .
The conventional coagulation assays used in this paper (aPTT, dRVVT, dKCT) measure the time to generate a thrombin-dependent clot. This usually takes less than one minute in plasma using the above tests. However the time to form a clot is a poor indicator of thrombin generation; because it occurs before peak thrombin production (15) . The use of a colorimetric thrombin substrate in defibrinated plasma gives more reliable information about thrombin generation over time. This may be of importance clinically as APS patients have evidence of a continuously elevated level of thrombin (16) and an ongoing tendency to thrombosis. In summary, analysis of our β2GPI-null mice reveal a possible role of this plasma protein in early embryonic fetal development in some mouse strains.
However, any function of β2GPI is likely to be limited to providing a selective by guest on April 8, 2017
